Canada · Health Canada Drug Product Database
TRYPTOPHAN
Source ingredient · 126 source records
Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.
OLIMEL 5.7% E
Emulsion / BAXTER CORPORATION
OLIMEL 7.6%
Emulsion / BAXTER CORPORATION
OLIMEL 7.6% E
Emulsion / BAXTER CORPORATION
PERIOLIMEL 2.5% E
Emulsion / BAXTER CORPORATION
PHL-TRYPTOPHAN
Tablet / PHARMEL INC
PHL-TRYPTOPHAN
Tablet / PHARMEL INC
PHL-TRYPTOPHAN
Capsule / PHARMEL INC
PMS-TRYPTOPHAN
Tablet / PHARMASCIENCE INC
PMS-TRYPTOPHAN
Tablet / PHARMASCIENCE INC
PMS-TRYPTOPHAN
Capsule / PHARMASCIENCE INC
PRIMENE 10%
Liquid / BAXTER CORPORATION
PRIMENE 10%-LIQ IV
Liquid / CLINTEC NUTRITION COMPANY
QUICK MIX 2.5% TRAVASOL AA WITH ELECTROLYTES WITH 25% DEXTROSE INJEC
Liquid / BAXTER CORPORATION CLINTEC NUTRITION DIVISION
RENAMIN (AMINO ACIDS) INJECTION
Solution / BAXTER CORPORATION
SMOFKABIVEN
Emulsion / FRESENIUS KABI CANADA LTD
SMOFKABIVEN ELECTROLYTE FREE
Emulsion / FRESENIUS KABI CANADA LTD
SMOFKABIVEN EXTRA NITROGEN
Emulsion / FRESENIUS KABI CANADA LTD
SMOFKABIVEN EXTRA NITROGEN ELECTROLYTE FREE
Emulsion / FRESENIUS KABI CANADA LTD
SMOFKABIVEN PERIPHERAL
Emulsion / FRESENIUS KABI CANADA LTD
TEVA-TRYPTOPHAN
Tablet / TEVA CANADA LIMITED
TEVA-TRYPTOPHAN
Tablet / TEVA CANADA LIMITED
TEVA-TRYPTOPHAN
Capsule / TEVA CANADA LIMITED
TRAVASOL
Solution / BAXTER CORPORATION
TRAVASOL
Solution / BAXTER CORPORATION
TRAVASOL AMINO ACID INJ 5.5%
Solution / BAXTER CORPORATION
TRAVASOL AMINO ACID INJ 8.5%
Solution / BAXTER CORPORATION
TRAVASOL E
Solution / BAXTER CORPORATION
TRAVASOL INJ WITHOUT ELECTROLYTES 5.5%
Solution / BAXTER CORPORATION
TRAVASOL INJ WITHOUT ELECTROLYTES 8.5%
Solution / BAXTER CORPORATION
TRYPTAN
Tablet / BAUSCH HEALTH, CANADA INC.